These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16584448)

  • 1. Donor screening for agents of bioterror.
    Schmidt M; Roth WK; Seifried E; Hourfar MK
    Transfusion; 2006 Apr; 46(4):678; author reply 678-9. PubMed ID: 16584448
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood donor screening for agents of bioterror: more questions than answers.
    Katz LM; Sayers M
    Transfusion; 2005 Mar; 45(3):290-2. PubMed ID: 15752144
    [No Abstract]   [Full Text] [Related]  

  • 3. Detecting bioterror attacks by screening blood donors: a best-case analysis.
    Kaplan EH
    Emerg Infect Dis; 2003 Aug; 9(8):909-14. PubMed ID: 12967486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Japan.
    Yugi H; Hino S; Satake M; Tadodoro K
    Vox Sang; 2005 Nov; 89(4):265. PubMed ID: 16262762
    [No Abstract]   [Full Text] [Related]  

  • 5. Virus inactivation procedures: an overview.
    Tedder R
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S13-4. PubMed ID: 7495960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood supply safety: an NHLBI perspective.
    Glynn SA
    Transfusion; 2008 Aug; 48(8):1541-4. PubMed ID: 18713102
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians' preparedness for bioterrorism and other public health priorities.
    Alexander GC; Larkin GL; Wynia MK
    Acad Emerg Med; 2006 Nov; 13(11):1238-41. PubMed ID: 16614456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viral biosafety, biosecurity, and bioterrorism].
    Garin D
    Med Trop (Mars); 2010 Feb; 70(1):28-32. PubMed ID: 20337111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting bioterror attack.
    Bicout DJ
    Emerg Infect Dis; 2004 Aug; 10(8):1504-5; author reply 1505-6. PubMed ID: 15503398
    [No Abstract]   [Full Text] [Related]  

  • 11. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
    Van der Bij AK; Coutinho RA; Van der Poel CL
    Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of viral pathogens as agents of bioterrorism.
    Bronze MS; Voskuhl GW; Machado LJ; Greenfield RA
    J Okla State Med Assoc; 2003 Jan; 96(1):29-33. PubMed ID: 12632851
    [No Abstract]   [Full Text] [Related]  

  • 13. Pre-donation screening of intending blood donors for antibodies to infectious agents in a Nigerian tertiary health institution: a pilot study.
    Salawu L; Murainah HA
    Afr J Med Med Sci; 2006 Dec; 35(4):453-6. PubMed ID: 17722812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors.
    Busch MP
    Transfusion; 2006 Oct; 46(10):1663-6. PubMed ID: 17002621
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
    Fasola FA; Kotila TR; Akinyemi JO
    Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Category B potential bioterrorism agents: bacteria, viruses, toxins, and foodborne and waterborne pathogens.
    Pappas G; Panagopoulou P; Christou L; Akritidis N
    Infect Dis Clin North Am; 2006 Jun; 20(2):395-421, x. PubMed ID: 16762744
    [No Abstract]   [Full Text] [Related]  

  • 18. The surgeon and acts of civilian terrorism: biologic agents.
    Fry DE; Schecter WP; Parker JS; Quebbeman EJ;
    J Am Coll Surg; 2005 Feb; 200(2):291-302. PubMed ID: 15664107
    [No Abstract]   [Full Text] [Related]  

  • 19. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006.
    Polizzotto MN; Wood EM; Ingham H; Keller AJ;
    Transfusion; 2008 Jan; 48(1):55-63. PubMed ID: 17894794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. West Nile virus transmission via organ transplantation and blood transfusion - Louisiana, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(45):1263-7. PubMed ID: 19940831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.